300 Results (Page 1 of 12)
Vietnam Markets Research Reports
Vietnam Dental Care Market Analysis
Vietnam's dental care market was valued at $6.595 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.93% from 2022 to 2030 and will reach $15.122 Bn in 2030. One of the main reasons propelling the growth of this market demand for primary and postoperative care of higher quality is technological advancement. The market is segmented by services, dental clinics, and revenue. Some key players in this market are Nha Khoa Kim, Nha Khoa Paris Dental Group, Nha Khoa Dang Luu, Anna Dental Care, etc.
Vietnam Cardiac Arrhythmia Therapeutics Market Analysis
Vietnam Cardiac Arrhythmia Therapeutics Market valued at $36 Mn in 2022, projected to reach $58 Mn by 2030 with a 6.03% CAGR. The key drivers of this industry include the rising incidence of cardiac arrhythmias, government initiatives, and increasing healthcare expenditure. The industry is primarily dominated by players such as Abbott, Mylan, Sun Pharma, Novartis, Bayer, Fresenius, Johnson & Johnson, and Medtronic among others.
Vietnam Alzheimer’s Therapeutics Market Analysis
Vietnam alzheimer’s therapeutics market valued at $24 Mn in 2022, projected to reach $49 Mn by 2030 with a 9.33% CAGR. The growing prevalence of Alzheimer's disease, which is fuelled by an aging population, is the main factor driving the market for drugs used to treat the condition. The top pharmaceutical firms in the industry currently operating in the market are Eisai, Biogen, GlaxoSmithKline, Novartis, Pfizer, Roche, Johnson & Johnson, Eli Lilly, AstraZeneca and Merck & Co.
Vietnam Infectious Disease Drugs Market Analysis
Vietnam Infectious Disease Drugs Market valued at $0.59 Bn in 2023, projected to reach $0.81 Bn by 2030 with a 4.5% CAGR. The industry is influenced by factors such as government healthcare programs, rising infectious disease prevalence, and technological improvements. The market is dominated by key players like Mekophar, Hau Giang Pharmaceutical, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Vietnam Atopic Dermatitis Therapeutics Market Analysis
The Vietnam Atopic Dermatitis Therapeutics Market was valued at US $62 Mn in 2022, and is predicted to grow at (CAGR) of 9.03% from 2023 to 2030, to US $123 Mn by 2030. The key drivers of this industry include the increased burden of Atopic Dermatitis (AD), improving healthcare infrastructure, shifting patient preferences, and others. The industry is primarily dominated by players such as Sanofi, Pharmacity, Merck, AbbVie, Domesco, Novartis, and Johnson & Johnson, among others.
Vietnam Atherosclerosis Therapeutics Market Analysis
Vietnam Atherosclerosis Therapeutics Market was valued at $14 Mn in 2022 and is estimated to reach $22 Mn in 2030, exhibiting a CAGR of 5.93% during the forecast period. The rising prevalence of cardiovascular diseases, exacerbated by unhealthy dietary patterns, sedentary lifestyles, and a growing aging population worldwide, is anticipated to increase the need for atherosclerosis therapeutics. Leading pharmaceutical companies currently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Abbott, Eli Lilly, Roche, Teva Pharmaceutical and Johnson & Johnson.
Vietnam Asthma and COPD Therapeutics Market Analysis
The Vietnam Asthma and COPD Therapeutics Market was valued at US $167 Mn in 2022, and is predicted to grow at (CAGR) of 5.43% from 2023 to 2030, to US $255 Mn by 2030. The key drivers of this industry include the surge in the prevalence of COPD and asthma, supportive government initiatives, improved healthcare infrastructure, and others. The industry is primarily dominated by players such as Abbott, Mekophar, AstraZeneca, Traphaco, Novartis, Pharimexco, and GSK, among others.
Vietnam Anemia Therapeutics Market Analysis
The Vietnam Anemia Therapeutics Market is anticipated to experience a growth from $74 Mn in 2022 to $151 Mn by 2030, with a CAGR of 9.3% during the forecast period of 2022-2030. High anemia prevalence, changing demographic trends and urbanization, and increased government support in the betterment of healthcare access among the population are among some factors that boost Vietnam market. The Vietnam Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, Roche, Bayer, Johnson & Johnson, Sanofi, AstraZeneca, Traphaco, Mekophar, Sao Kim Pharmaceutical etc, among various others
Vietnam HIV Drugs Market Analysis
Vietnam HIV Drugs Market is at around $0.16 Bn in 2023 and is projected to reach $0.21 Bn in 2030, exhibiting a CAGR of 3.83% during the forecast period. Rising expenditure on healthcare, innovation in drug development, and international alliances and funding drive growth in the market. The market is dominated by key players like Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffmann-La Roche Ltd., Novartis, and Mylan.
Vietnam Antifungal Drugs Market Analysis
Vietnam Antifungal Drugs Market is at around $0.07 Bn in 2023 and is projected to reach $0.01 Bn in 2030, exhibiting a CAGR of 4.03% during the forecast period. The market is expanding due to factors like changing lifestyles and urbanization, improvements in healthcare infrastructure, and increased public awareness of fungal infections. The market is dominated by key players like Sanofi-Aventis, Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, and Gilead Sciences Inc.
Vietnam ePharmacy Market Analysis
This report presents a strategic analysis of the Vietnam ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam ePharmacy Market, offering unmatched value, accuracy, and expert insights.
Vietnam Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Vietnam Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.
Vietnam Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the Vietnam Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Patient Support Programs (PSP) Market, offering unmatched value, accuracy, and expert insights.
Vietnam Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Orphan Diseases Drugs Market, offering unmatched value, accuracy, and expert insights.
Vietnam Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Vietnam Lung Cancer Therapeutics Market will reach a value of $283 Mn from $149 Mn in 2022, growing at a CAGR of 8.3% during 2022-30. The Lung Cancer Therapeutics Market in Vietnam is dominated by a few domestic pharmaceutical companies such as Hau Giang Pharmaceutical, Traphaco, and Vietnam Pharmaceutical. The Lung Cancer Therapeutics Market in Vietnam is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Vietnam lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.
Vietnam Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Vietnam liver cancer therapeutics market will reach a value of $54.4 Mn from $14.65 Mn in 2022, growing at a CAGR of 17.8% during 2022-30. Liver cancer therapeutics in Vietnam are dominated by a few domestic pharmaceutical companies such as OPC Pharmaceutical, Vimedimex Medi-Pharma, and Hau Giang Pharmaceutical. The liver cancer therapeutics market in Vietnam is segmented into different types of cancer and different therapy types. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Vietnam Insulin Market Analysis
This report presents a strategic analysis of the Vietnam Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Insulin Market, offering unmatched value, accuracy, and expert insights.
Vietnam Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Vietnam Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
Vietnam ENT Devices Market Analysis
Vietnam ENT Devices Market is projected to grow from $120 Mn in 2022 to $180 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Vietnam ENT devices market include Medtek Corporation, Anova Corporation, and Nam Quang Medical.
Vietnam Digital Therapeutics Market Analysis
Vietnam Digital Therapeutics Market is at around $31 Mn in 2023 and is projected to reach $169.15 Mn in 2030, exhibiting a CAGR of 27.43 % during the forecast period. The growing prevalence of chronic diseases, government initiatives, and technological developments are fuelling the growth of the market. The market is dominated by key players like Pharmacy, Vinmec Health System, DarioHealth Corp., Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, and Noom Inc.
Vietnam Dialysis Market Analysis
This report presents a strategic analysis of the Vietnam Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Dialysis Market, offering unmatched value, accuracy, and expert insights.
Vietnam Diabetes Therapeutics Market Analysis
Vietnam's diabetes therapeutics market is expected to witness growth from $719 Mn in 2022 to $1,534 Mn in 2030 with a CAGR of 9.93% for the forecasted year 2022-30. The rising prevalence of diabetes and the increasing adoption of unhealthy lifestyle choices are resulting in the growth of the market. The Vietnam diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Vn Xun Pharma, Agimexpharm, and Eli Lilly are the major players in the Vietnam diabetes therapeutics market.
Vietnam Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.
Vietnam Systemic Lupus Erythematosus Market Analysis
Vietnam Systemic Lupus Erythematosus Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Systemic Lupus Erythematosus market is growing globally due to the rise in the prevalence of systemic lupus erythematosus across the world, increasing geriatric population and rising healthcare expenditure, advances in research and development for introduction of novel therapies, Growing Awareness and Diagnosis and Government Initiatives and Support. GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Bristol Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, AbbVie Inc. are the key global market players in Systemic Lupus Erythematosus Market.
Vietnam T-Cell Lymphoma Market Analysis
Vietnam T-Cell Lymphoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. T-Cell Lymphoma market is growing globally due to the High lymphoma cancer incidence rate, rising healthcare expenditure, rising number of geriatric population, increasing risk of lymphoma due to autoimmune disorders, high disposable income, advancement in T-cell lymphoma-specific therapies, unmet medical needs, advances in diagnostic techniques and increasing utilization of immunotherapies. Bristol Myers Squibb Company, Novartis AG, Kyowa Kirin Co., Ltd., Merck & Co., Inc., Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., BeiGene, Ltd., and Epizyme, Inc. are the key global market players in T-Cell Lymphoma Market.